Indications and uses
helps prevent sunburn. If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
BB Tinted Treatment 12-hour Primer Broad Spectrum SPF 30 Sunscreen
- Manufacturer
- Tarte, Inc
- Effective date
- 2018-03-27
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:00:11
Label at a glance#
ProductBB Tinted Treatment 12-hour Primer Broad Spectrum SPF 30 Sunscreen Fair
Active ingredientTitanium Dioxide, Zinc Oxide
Label structure14 sections
Dosage and administration
Apply liberally 15 minutes before sun exposure Use a water resistant sunscreen if swimming or sweating Reapply at least every 2 hours Children under 6 months: Ask a doctor Optional: apply to all skin exposed to the sun Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or ...
Storage and handling
Protect the product in this container from excessive heat and direct sunlight You may report a serious adverse reaction to: tarte c/o Report Reaction, LLC, P.O. Box 22, Plainsboro, New Jersey 08536-0222.
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active ingredients | Purpose |
|---|---|
| Titanium Dioxide 4.55% | Sunscreen |
| Zinc Oxide 3.50% | Sunscreen |
Uses
- helps prevent sunburn.
- If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
OTC - STOP USE SECTION
Stop use and ask doctor if rash occurs
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally 15 minutes before sun exposure
- Use a water resistant sunscreen if swimming or sweating
- Reapply at least every 2 hours
- Children under 6 months: Ask a doctor
- Optional: apply to all skin exposed to the sun
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- Limit time in the sun, especially from 10 a.m.-2 p.m.
- Wear long-sleeved shirts, pants, hats and sunglasses
Other information
- Protect the product in this container from excessive heat and direct sunlight
- You may report a serious adverse reaction to: tarte c/o Report Reaction, LLC, P.O. Box 22, Plainsboro, New Jersey 08536-0222.
Inactive ingredients
Cyclopentasiloxane, isododecane, mica, polysilicone-11, polymethylsilsesquioxane, hexyl laurate, PEG-10 dimethicone, polyglyceryl-4 isostearate, stearic acid, cetyl PEG/PPG-10/1 dimethicone, alumina, triethoxycaprylylsilane, dipalmitoyl hydroxyproline, diamond powder, iron oxides.
SPL UNCLASSIFIED SECTION
Dist. by tarte™, Inc. NY 10018.
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - Fair
tarte
high-performance naturals™
BB tinted treatment primer
Broad Spectrum
SPF 30 Sunscreen
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - Light
tarte
high-performance naturals™
BB tinted treatment primer
Broad Spectrum
SPF 30 Sunscreen
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - Medium
tarte
high-performance naturals™
BB tinted treatment primer
Broad Spectrum
SPF 30 Sunscreen
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - Tan-Deep
tarte
high-performance naturals™
BB tinted treatment primer
Broad Spectrum
SPF 30 Sunscreen
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - Tan
tarte
high-performance naturals™
BB tinted treatment 12-hour primer
Broad Spectrum
SPF 30 Sunscreen
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - Medium-Tan
tarte
high-performance naturals™
BB tinted treatment primer
Broad Spectrum
SPF 30 Sunscreen
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| aluminum oxide | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| diamond | INACTIVE INGREDIENT | 6GRV67N0U2 | 1 | |
| dipalmitoyl hydroxyproline | INACTIVE INGREDIENT | E6AHA53N1H | 1 | |
| hexyl laurate | INACTIVE INGREDIENT | 4CG9F9W01Q | 1 | |
| isododecane | INACTIVE INGREDIENT | A8289P68Y2 | 1 | |
| mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| polyglyceryl-4 isostearate | INACTIVE INGREDIENT | 820DPX33S7 | 1 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| triethoxycaprylylsilane | INACTIVE INGREDIENT | LDC331P08E | 1 |
Products#
Every source-derived product name is available through these pages.
- BB Tinted Treatment 12-hour Primer Broad Spectrum SPF 30 Sunscreen Fair
- Titanium Dioxide and Zinc Oxide
- Titanium Dioxide
- Zinc Oxide
- cyclomethicone 5
- isododecane
- mica
- hexyl laurate
- polyglyceryl-4 isostearate
- stearic acid
- aluminum oxide
- triethoxycaprylylsilane
- dipalmitoyl hydroxyproline
- diamond
- BB Tinted Treatment 12-hour Primer Broad Spectrum SPF 30 Sunscreen Light
- BB Tinted Treatment 12-hour Primer Broad Spectrum SPF 30 Sunscreen Medium
- BB Tinted Treatment 12-hour Primer Broad Spectrum SPF 30 Sunscreen Tan Deep
- BB Tinted Treatment 12-hour Primer Broad Spectrum SPF 30 Sunscreen Tan
- BB Tinted Treatment 12-hour Primer Broad Spectrum SPF 30 Sunscreen Medium-Tan
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 51060-018 | 51060-018-01 |
| 51060-019 | 51060-019-01 |
| 51060-020 | 51060-020-01 |
| 51060-023 | 51060-023-01 |
| 51060-022 | 51060-022-01 |
| 51060-021 | 51060-021-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| stearic acid | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | 80 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET / SUBLINGUAL | 9 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CREAM / VAGINAL | 1088 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | SPONGE / TOPICAL | NA | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 94ffe32e-62e8-445d-b102-d57706cac4c4 | 7ae3c9c6-254e-4fad-974e-3e2ff295b19f | 2021-02-18 | Warnings | 7ae3c9c6-254e-4fad-974e-3e2ff295b19f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.